Isoniazid Trial - Regional TB and Mycobacterial Infections Journal Club
Автор: ACTnet (Australasian Clinical TB Network)
Загружено: 2024-08-01
Просмотров: 44
Описание:
Isoniazid is a highly potent tuberculosis drug. Evidence suggests that higher-than-standard doses of isoniazid may benefit patients with isoniazid-resistant tuberculosis caused by Mycobacterium tuberculosis strains with inhA mutations. Whether “high dose” isoniazid benefits patients with isoniazid-resistant tuberculosis caused by strains with katG mutations is unknown.
In this edition of the Journal Club we discussed the trial.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: